In January, Novo Nordisk ( NVO +0.10%) broke new ground in the weight-loss market by launching an oral version of its famous anti-obesity drug, Wegovy. It's the first oral GLP-1 approved for chronic ...
Russell Crowe previously discussed how he lost 55 pounds with the help of the Ways2Well program. Here's what to know.
I approached my weight loss as a lifestyle change, adjusting my habits, exercise routine, and diet in a way that felt ...
A recent small study has found that people may be able to maintain their weight loss with fewer GLP-1 injections, but this ...
“Every single study of weight loss shows that when you just count your calories and eat less, your basal metabolic rate—the ...
Novo Nordisk has multiple weight-loss drugs in various stages of development and approval, according to its R&D pipeline. These include, among others, monlunabant (phase 2); oral and subcutaneous ...
'The Price is Right' host Drew Carey lost 80 lbs. in 2010 ...
By John Revill and Danny Callaghan KILCHBERG, Switzerland March 10 (Reuters) - Chocolate sales are rising faster among U.S. users of GLP-1 weight-loss drugs than in the rest of the population, Swiss ...
A new study presented at the American Academy of Orthopaedic Surgeons (AAOS) 2026 Annual Meeting suggests that weight-loss drugs may increase the risk of fractures and gout. Here is what you should ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results